Ophthalmic Immune-Related Adverse Events in Cancer Immunotherapy: Tissue-Specific Mechanisms, Clinical Phenotypes, and Consensus-Based Management.

Zong Y, Yang M, Zhang J, Zou Y, Ye Z, Deng J, Gu W, Ohno-Matsui K, Kamoi K

Int J Mol Sci. 2026 Jul 01; 27(13). PMID: 42450211. Abstract